These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 16471320

  • 1. Interstitial transfer factor as adjuvant immunotherapy for experimental glioma.
    Pineda B, Estrada-Parra S, Pedraza-Medina B, Rodriguez-Ropon A, Pérez R, Arrieta O.
    J Exp Clin Cancer Res; 2005 Dec; 24(4):575-83. PubMed ID: 16471320
    [Abstract] [Full Text] [Related]

  • 2. Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis.
    Fabre RA, Pérez TM, Aguilar LD, Rangel MJ, Estrada-Garcìa I, Hernández-Pando R, Estrada Parra S.
    Clin Exp Immunol; 2004 May; 136(2):215-23. PubMed ID: 15086383
    [Abstract] [Full Text] [Related]

  • 3. Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells.
    Fecci PE, Sweeney AE, Grossi PM, Nair SK, Learn CA, Mitchell DA, Cui X, Cummings TJ, Bigner DD, Gilboa E, Sampson JH.
    Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4294-305. PubMed ID: 16857805
    [Abstract] [Full Text] [Related]

  • 4. Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors.
    El Andaloussi A, Sonabend AM, Han Y, Lesniak MS.
    Glia; 2006 Nov 01; 54(6):526-35. PubMed ID: 16906541
    [Abstract] [Full Text] [Related]

  • 5. Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells.
    Ren H, Tan X, Dong Y, Giese A, Chou TC, Rainov N, Yang B.
    Basic Clin Pharmacol Toxicol; 2009 Mar 01; 104(3):241-52. PubMed ID: 19159435
    [Abstract] [Full Text] [Related]

  • 6. Experimental study on the treatment of intracerebral glioma xenograft with human cytokine-induced killer cells.
    Wang P, Yu JP, Gao SY, An XM, Ren XB, Wang XG, Li WL.
    Cell Immunol; 2008 Mar 01; 253(1-2):59-65. PubMed ID: 18522858
    [Abstract] [Full Text] [Related]

  • 7. Immunotherapy for human glioma: innovative approaches and recent results.
    Hussain SF, Heimberger AB.
    Expert Rev Anticancer Ther; 2005 Oct 01; 5(5):777-90. PubMed ID: 16221048
    [Abstract] [Full Text] [Related]

  • 8. Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
    Tran TT, Uhl M, Ma JY, Janssen L, Sriram V, Aulwurm S, Kerr I, Lam A, Webb HK, Kapoun AM, Kizer DE, McEnroe G, Hart B, Axon J, Murphy A, Chakravarty S, Dugar S, Protter AA, Higgins LS, Wick W, Weller M, Wong DH.
    Neuro Oncol; 2007 Jul 01; 9(3):259-70. PubMed ID: 17522330
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of inducible nitric oxide synthase enhances anti-tumour immune responses in rats immunized with IFN-gamma-secreting glioma cells.
    Badn W, Hegardt P, Fellert MA, Darabi A, Esbjörnsson M, Smith KE, Janelidze S, Salford LG, Visse E, Siesjö P.
    Scand J Immunol; 2007 Mar 01; 65(3):289-97. PubMed ID: 17309784
    [Abstract] [Full Text] [Related]

  • 10. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas.
    Newcomb EW, Demaria S, Lukyanov Y, Shao Y, Schnee T, Kawashima N, Lan L, Dewyngaert JK, Zagzag D, McBride WH, Formenti SC.
    Clin Cancer Res; 2006 Aug 01; 12(15):4730-7. PubMed ID: 16899624
    [Abstract] [Full Text] [Related]

  • 11. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr 01; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 12. T-cell apoptosis in human glioblastoma multiforme: implications for immunotherapy.
    Walker DG, Chuah T, Rist MJ, Pender MP.
    J Neuroimmunol; 2006 Jun 01; 175(1-2):59-68. PubMed ID: 16631933
    [Abstract] [Full Text] [Related]

  • 13. Intracerebral interleukin 12 induces glioma rejection in the brain predominantly by CD8+ T cells and independently of interferon-gamma.
    Vetter M, Hofer MJ, Roth E, Pircher HP, Pagenstecher A.
    J Neuropathol Exp Neurol; 2009 May 01; 68(5):525-34. PubMed ID: 19525900
    [Abstract] [Full Text] [Related]

  • 14. Nitric oxide donors attenuate clongenic potential in rat C6 glioma cells treated with alkylating chemotherapeutic agents.
    Yang JJ, Yin JH, Yang DI.
    Neurosci Lett; 2007 May 11; 418(1):106-10. PubMed ID: 17412510
    [Abstract] [Full Text] [Related]

  • 15. Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFNgamma-transduced tumor cell immunotherapy of experimental glioma.
    Gunnarsson S, Bexell D, Svensson A, Siesjö P, Darabi A, Bengzon J.
    J Neuroimmunol; 2010 Jan 25; 218(1-2):140-4. PubMed ID: 19914721
    [Abstract] [Full Text] [Related]

  • 16. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C.
    Exp Hematol; 2007 Mar 25; 35(3):416-25. PubMed ID: 17309822
    [Abstract] [Full Text] [Related]

  • 17. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
    Varker KA, Kondadasula SV, Go MR, Lesinski GB, Ghosh-Berkebile R, Lehman A, Monk JP, Olencki T, Kendra K, Carson WE.
    Clin Cancer Res; 2006 Oct 01; 12(19):5850-8. PubMed ID: 17020993
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-2 and histamine in combination inhibit tumour growth and angiogenesis in malignant glioma.
    Johansson M, Henriksson R, Bergenheim AT, Koskinen LO.
    Br J Cancer; 2000 Sep 01; 83(6):826-32. PubMed ID: 10952789
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma.
    Yuan X, Hu J, Belladonna ML, Black KL, Yu JS.
    Cancer Res; 2006 Mar 01; 66(5):2630-8. PubMed ID: 16510582
    [Abstract] [Full Text] [Related]

  • 20. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model.
    Chang CY, Lee J, Kim EY, Park HJ, Kwon CH, Joh JW, Kim SJ.
    BMC Cancer; 2007 May 23; 7():87. PubMed ID: 17519043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.